Department of Ophthalmology, Yachiyo Medical Center, Tokyo Women's Medical University, 477-96, Owada-shinden, Yachiyo, Chiba, 276-8524, Japan.
Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1559-65. doi: 10.1007/s00417-010-1486-7. Epub 2010 Aug 17.
We investigated whether pigment epithelium-derived factor (PEDF) or vascular endothelial growth factor (VEGF) influence macular edema in patients with branch retinal vein occlusion (BRVO). This investigation aimed to clarify the influence of PEDF in the vitreous fluid on retinal vascular permeability in patients with macular edema secondary to BRVO. The findings were expected to be useful for the treatment of macular edema in BRVO patients.
This was a retrospective cross-sectional comparative case series. Thirty-three BRVO patients with macular edema and 24 control patients with nonischemic ocular diseases were enrolled. Retinal ischemia was evaluated by measuring the area of capillary nonperfusion on fluorescein angiography with Scion Image software. Macular edema was examined by optical coherence tomography. Vitreous fluid samples were obtained via pars plana vitrectomy, and the VEGF and PEDF levels were determined by enzyme-linked immunosorbent assay.
The vitreous level of VEGF was significantly higher in BRVO patients than controls (P < 0.001). The vitreous PEDF level was significantly lower in BRVO patients than controls (P = 0.026). In BRVO patients, vitreous levels of PEDF and VEGF showed a significant negative correlation with each other (P < 0.001). Additionally, the vitreous VEGF level had a significant positive correlation (P < 0.001) and the vitreous PEDF level had a significant negative correlation (P < 0.001) with the nonperfused retinal area in BRVO patients. Furthermore, vitreous levels of VEGF and PEDF showed significant positive (P = 0.001) and negative (P = 0.014) correlations, respectively, with macular edema in BRVO patients.
VEGF and PEDF may inversely influence retinal vascular permeability in patients with ischemic BRVO and macular edema. However, prospective validation will be needed to confirm these observations.
我们研究了色素上皮衍生因子(PEDF)或血管内皮生长因子(VEGF)是否影响视网膜分支静脉阻塞(BRVO)患者的黄斑水肿。本研究旨在阐明 BRVO 继发黄斑水肿患者玻璃体内 PEDF 对视网膜血管通透性的影响。我们希望这些发现对 BRVO 患者黄斑水肿的治疗有所帮助。
这是一项回顾性的病例对照横断面研究。共纳入 33 例 BRVO 合并黄斑水肿患者和 24 例非缺血性眼病对照患者。通过 Scion Image 软件分析荧光素眼底血管造影的毛细血管无灌注面积来评估视网膜缺血。采用光学相干断层扫描(OCT)检查黄斑水肿。通过经睫状体平坦部玻璃体切割术获取玻璃体样本,采用酶联免疫吸附试验(ELISA)检测 VEGF 和 PEDF 水平。
BRVO 患者的玻璃体 VEGF 水平明显高于对照组(P<0.001)。BRVO 患者的玻璃体 PEDF 水平明显低于对照组(P=0.026)。BRVO 患者的玻璃体 PEDF 与 VEGF 水平呈显著负相关(P<0.001)。此外,BRVO 患者的玻璃体 VEGF 水平与无灌注视网膜面积呈显著正相关(P<0.001),玻璃体 PEDF 水平与无灌注视网膜面积呈显著负相关(P<0.001)。此外,BRVO 患者的玻璃体 VEGF 和 PEDF 水平与黄斑水肿呈显著正相关(P=0.001)和负相关(P=0.014)。
VEGF 和 PEDF 可能会对缺血性 BRVO 和黄斑水肿患者的视网膜血管通透性产生相反的影响。然而,还需要前瞻性验证来证实这些观察结果。